CLAY B SIEGALL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CLAY B SIEGALL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CLAY B SIEGALL. CLAY B SIEGALL is President & CEO in SEATTLE GENETICS INC /WA ($SGEN) and President and CEO in SEATTLE GENETICS INC /WA ($SGEN) and See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Mirna Therapeutics, Inc. ($MIRN).
Latest Insider Trading Transactions of CLAY B SIEGALL
Sentiment: All, ALDR, SGEN, SYBX, RARE
Page: < prev 1 2 3 4 5 6 7 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 113.39 | 8,286 | 939,550 | 758,784 | 767.1 K to 758.8 K (-1.08 %) |
| Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 8,286 | 99,432 | 767,070 | 758.8 K to 767.1 K (+1.09 %) |
| Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 114.32 | 9,939 | 1,136,226 | 758,784 | 768.7 K to 758.8 K (-1.29 %) |
| Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 9,939 | 119,268 | 768,723 | 758.8 K to 768.7 K (+1.31 %) |
| Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 115.38 | 5,002 | 577,131 | 758,784 | 763.8 K to 758.8 K (-0.65 %) |
| Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 5,002 | 60,024 | 763,786 | 758.8 K to 763.8 K (+0.66 %) |
| Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 116.34 | 5,245 | 610,203 | 758,784 | 764 K to 758.8 K (-0.69 %) |
| Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 5,245 | 62,940 | 764,029 | 758.8 K to 764 K (+0.69 %) |
| Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 27,153 | 325,836 | 199,307 | |
| Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 1,319 | 15,828 | 226,460 | |
| Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 111.28 | 27,153 | 3,021,586 | 758,784 | 785.9 K to 758.8 K (-3.45 %) |
| Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 27,153 | 325,836 | 785,937 | 758.8 K to 785.9 K (+3.58 %) |
| Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 112.09 | 1,319 | 147,847 | 758,784 | 760.1 K to 758.8 K (-0.17 %) |
| Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 1,319 | 15,828 | 760,103 | 758.8 K to 760.1 K (+0.17 %) |
| Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 27,153 | 325,836 | 199,307 | |
| Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 1,319 | 15,828 | 226,460 | |
| Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 111.28 | 27,153 | 3,021,586 | 758,784 | 785.9 K to 758.8 K (-3.45 %) |
| Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 27,153 | 325,836 | 785,937 | 758.8 K to 785.9 K (+3.58 %) |
| Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 112.09 | 1,319 | 147,847 | 758,784 | 760.1 K to 758.8 K (-0.17 %) |
| Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 1,319 | 15,828 | 760,103 | 758.8 K to 760.1 K (+0.17 %) |
| Dec 23 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Grant | A | 0.00 | 3,100 | 0 | 758,784 | 755.7 K to 758.8 K (+0.41 %) |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 500 | 6,000 | 227,779 | |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 1,800 | 21,600 | 228,279 | |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 2,111 | 25,332 | 230,079 | |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 6,734 | 80,808 | 232,190 | |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 17,327 | 207,924 | 238,924 | |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 117.76 | 500 | 58,880 | 755,684 | 756.2 K to 755.7 K (-0.07 %) |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 500 | 6,000 | 756,184 | 755.7 K to 756.2 K (+0.07 %) |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 116.98 | 1,800 | 210,564 | 755,684 | 757.5 K to 755.7 K (-0.24 %) |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 1,800 | 21,600 | 757,484 | 755.7 K to 757.5 K (+0.24 %) |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 115.53 | 2,111 | 243,884 | 755,684 | 757.8 K to 755.7 K (-0.28 %) |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 2,111 | 25,332 | 757,795 | 755.7 K to 757.8 K (+0.28 %) |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 114.59 | 6,734 | 771,649 | 755,684 | 762.4 K to 755.7 K (-0.88 %) |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 6,734 | 80,808 | 762,418 | 755.7 K to 762.4 K (+0.89 %) |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 114.08 | 17,327 | 1,976,664 | 755,684 | 773 K to 755.7 K (-2.24 %) |
| Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 17,327 | 207,924 | 773,011 | 755.7 K to 773 K (+2.29 %) |
| Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 20,799 | 249,588 | 256,251 | |
| Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 3,968 | 47,616 | 277,050 | |
| Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 2,120 | 25,440 | 281,018 | |
| Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 1,585 | 19,020 | 283,138 | |
| Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 108.08 | 20,799 | 2,247,956 | 755,684 | 776.5 K to 755.7 K (-2.68 %) |
| Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 20,799 | 249,588 | 776,483 | 755.7 K to 776.5 K (+2.75 %) |
| Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 107.32 | 3,968 | 425,846 | 755,684 | 759.7 K to 755.7 K (-0.52 %) |
| Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 3,968 | 47,616 | 759,652 | 755.7 K to 759.7 K (+0.53 %) |
| Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 105.93 | 2,120 | 224,572 | 755,684 | 757.8 K to 755.7 K (-0.28 %) |
| Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 2,120 | 25,440 | 757,804 | 755.7 K to 757.8 K (+0.28 %) |
| Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 104.38 | 1,585 | 165,442 | 755,684 | 757.3 K to 755.7 K (-0.21 %) |
| Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 1,585 | 19,020 | 757,269 | 755.7 K to 757.3 K (+0.21 %) |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 11.01 | 22,500 | 247,725 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 15.50 | 15,000 | 232,500 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 16.90 | 15,000 | 253,500 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 29.26 | 15,000 | 438,900 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 39.66 | 6,350 | 251,841 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 6.33 | 6,363 | 40,246 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 3.47 | 6,363 | 22,048 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 3.47 | 6,363 | 22,048 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 3.96 | 6,363 | 25,197 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 4.46 | 6,363 | 28,347 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Sell | U | 18.00 | 31,714 | 570,852 | 0 | 31.7 K to 0 (-100.00 %) |
| Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 14,420 | 173,040 | 284,723 | |
| Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 13,352 | 160,224 | 299,143 | |
| Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 700 | 8,400 | 312,495 | |
| Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 82.01 | 14,420 | 1,182,584 | 755,684 | 770.1 K to 755.7 K (-1.87 %) |
| Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 14,420 | 173,040 | 770,104 | 755.7 K to 770.1 K (+1.91 %) |
| Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 82.89 | 13,352 | 1,106,747 | 755,684 | 769 K to 755.7 K (-1.74 %) |
| Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 13,352 | 160,224 | 769,036 | 755.7 K to 769 K (+1.77 %) |
| Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 83.90 | 700 | 58,730 | 755,684 | 756.4 K to 755.7 K (-0.09 %) |
| Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 700 | 8,400 | 756,384 | 755.7 K to 756.4 K (+0.09 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 18,690 | 224,280 | 313,195 | |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 9,257 | 111,084 | 331,885 | |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 18,690 | 224,280 | 313,195 | |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 521 | 6,252 | 341,142 | |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 9,257 | 111,084 | 331,885 | |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 4 | 48 | 341,663 | |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 521 | 6,252 | 341,142 | |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.00 | 18,690 | 1,270,920 | 755,684 | 774.4 K to 755.7 K (-2.41 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 4 | 48 | 341,663 | |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 18,690 | 224,280 | 774,374 | 755.7 K to 774.4 K (+2.47 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.00 | 18,690 | 1,270,920 | 755,684 | 774.4 K to 755.7 K (-2.41 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.91 | 9,257 | 637,900 | 755,684 | 764.9 K to 755.7 K (-1.21 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 18,690 | 224,280 | 774,374 | 755.7 K to 774.4 K (+2.47 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 9,257 | 111,084 | 764,941 | 755.7 K to 764.9 K (+1.22 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.91 | 9,257 | 637,900 | 755,684 | 764.9 K to 755.7 K (-1.21 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 69.92 | 521 | 36,428 | 755,684 | 756.2 K to 755.7 K (-0.07 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 9,257 | 111,084 | 764,941 | 755.7 K to 764.9 K (+1.22 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 521 | 6,252 | 756,205 | 755.7 K to 756.2 K (+0.07 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 69.92 | 521 | 36,428 | 755,684 | 756.2 K to 755.7 K (-0.07 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 70.80 | 4 | 283 | 755,684 | 755.7 K to 755.7 K (0.00 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 521 | 6,252 | 756,205 | 755.7 K to 756.2 K (+0.07 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 4 | 48 | 755,688 | 755.7 K to 755.7 K (0.00 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 70.80 | 4 | 283 | 755,684 | 755.7 K to 755.7 K (0.00 %) |
| Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 4 | 48 | 755,688 | 755.7 K to 755.7 K (0.00 %) |
| Sep 04 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Option Exercise | A | 72.64 | 112,762 | 8,191,032 | 112,762 | |
| Sep 04 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Option Exercise | A | 72.64 | 1,333 | 96,829 | 1,333 | |
| Sep 04 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Sell | S | 70.80 | 9,693 | 686,257 | 755,684 | 765.4 K to 755.7 K (-1.27 %) |
| Sep 04 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Grant | A | 0.00 | 48,034 | 0 | 765,377 | 717.3 K to 765.4 K (+6.70 %) |
| Aug 30 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 73.21 | 28,951 | 2,119,636 | 717,343 | 746.3 K to 717.3 K (-3.88 %) |
| Aug 09 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 2,300 | 27,968 | 0 | |
| Aug 09 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 7,951 | 96,684 | 2,300 | |
| Aug 09 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 9,898 | 120,360 | 10,251 | |
| Aug 09 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 75.25 | 2,300 | 173,075 | 746,294 | 748.6 K to 746.3 K (-0.31 %) |
| Aug 09 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 2,300 | 27,968 | 748,594 | 746.3 K to 748.6 K (+0.31 %) |
| Aug 09 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 76.43 | 7,951 | 607,695 | 746,294 | 754.2 K to 746.3 K (-1.05 %) |
| Aug 09 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 7,951 | 96,684 | 754,245 | 746.3 K to 754.2 K (+1.07 %) |
| Aug 09 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 76.89 | 9,898 | 761,057 | 746,294 | 756.2 K to 746.3 K (-1.31 %) |
| Aug 09 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 9,898 | 120,360 | 756,192 | 746.3 K to 756.2 K (+1.33 %) |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 14,717 | 178,959 | 20,149 | |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 5,231 | 63,609 | 34,866 | |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 200 | 2,432 | 40,097 | |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 66.71 | 14,717 | 981,771 | 746,294 | 761 K to 746.3 K (-1.93 %) |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 14,717 | 178,959 | 761,011 | 746.3 K to 761 K (+1.97 %) |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 67.33 | 5,231 | 352,203 | 746,294 | 751.5 K to 746.3 K (-0.70 %) |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 5,231 | 63,609 | 751,525 | 746.3 K to 751.5 K (+0.70 %) |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.45 | 200 | 13,690 | 746,294 | 746.5 K to 746.3 K (-0.03 %) |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 200 | 2,432 | 746,494 | 746.3 K to 746.5 K (+0.03 %) |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 14,717 | 178,959 | 20,149 | |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 5,231 | 63,609 | 34,866 | |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 200 | 2,432 | 40,097 | |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 66.71 | 14,717 | 981,771 | 746,294 | 761 K to 746.3 K (-1.93 %) |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 14,717 | 178,959 | 761,011 | 746.3 K to 761 K (+1.97 %) |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 67.33 | 5,231 | 352,203 | 746,294 | 751.5 K to 746.3 K (-0.70 %) |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 5,231 | 63,609 | 751,525 | 746.3 K to 751.5 K (+0.70 %) |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.45 | 200 | 13,690 | 746,294 | 746.5 K to 746.3 K (-0.03 %) |
| Jul 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 200 | 2,432 | 746,494 | 746.3 K to 746.5 K (+0.03 %) |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Grant | A | 0.00 | 3,000 | 0 | 9,750 | 6.8 K to 9.8 K (+44.44 %) |
| Jun 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 5,746 | 69,871 | 40,297 | |
| Jun 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 10,950 | 133,152 | 46,043 | |
| Jun 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 2,552 | 31,032 | 56,993 | |
| Jun 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 900 | 10,944 | 59,545 | |
| Jun 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Gift | G | 0.00 | 2,875 | 0 | 746,294 | 749.2 K to 746.3 K (-0.38 %) |
| Jun 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.21 | 5,746 | 391,935 | 749,169 | 754.9 K to 749.2 K (-0.76 %) |
| Jun 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 5,746 | 69,871 | 754,915 | 749.2 K to 754.9 K (+0.77 %) |
| Jun 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 69.13 | 10,950 | 756,974 | 749,169 | 760.1 K to 749.2 K (-1.44 %) |
| Jun 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 10,950 | 133,152 | 760,119 | 749.2 K to 760.1 K (+1.46 %) |
| Jun 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 69.90 | 2,552 | 178,385 | 749,169 | 751.7 K to 749.2 K (-0.34 %) |
| Jun 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 2,552 | 31,032 | 751,721 | 749.2 K to 751.7 K (+0.34 %) |
| Jun 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 70.98 | 900 | 63,882 | 749,169 | 750.1 K to 749.2 K (-0.12 %) |
| Jun 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 900 | 10,944 | 750,069 | 749.2 K to 750.1 K (+0.12 %) |
| May 28 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | A | 11.01 | 22,500 | 247,725 | 22,500 | |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 1,930 | 23,469 | 60,445 | |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 2,894 | 35,191 | 62,375 | |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 1,593 | 19,371 | 65,269 | |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 13,431 | 163,321 | 66,862 | |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 300 | 3,648 | 80,293 | |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 66.93 | 1,930 | 129,175 | 749,169 | 751.1 K to 749.2 K (-0.26 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 1,930 | 23,469 | 751,099 | 749.2 K to 751.1 K (+0.26 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 67.77 | 2,894 | 196,126 | 749,169 | 752.1 K to 749.2 K (-0.38 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 2,894 | 35,191 | 752,063 | 749.2 K to 752.1 K (+0.39 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 67.41 | 1,593 | 107,384 | 749,169 | 750.8 K to 749.2 K (-0.21 %) |